Comprehensive analysis of serum concentration of matrix metalloproteinase 1 and tissue inhibitor of metalloproteinase 1 in preschool children suffering from recurrent respiratory infections
DOI:
https://doi.org/10.15574/SP.2022.127.29Keywords:
preschool children, recurrent respiratory infections, matrix metalloproteinase 1, tissue inhibitor of matrix metalloproteinase 1Abstract
Introduction. Excessive intestinal inflammation in preterm infants is one of the key factors in the development of necrotizing enterocolitis (NEC), early- (EOS) and late-onset neonatal sepsis (LOS).
Purpose - to evaluate the connection between fecal calprotectin (FC), enteral use of lactoferrin (LF), and the occurrence of NEC, EOS, and LOS in preterm infants.
Materials and methods. FC was measured in 26 newborns with gestational age (GA) ≤32 weeks and birth weight ≤1500 g. Feces were collected twice: in the first 7 days of life and at the postmenstrual age (PMA) of 36 weeks. The main group included 15 infants with either EOS, LOS or NEC. The remaining 11 infants formed the comparison group. Eleven infants received LF (4 in the main group and 7 in the comparison group), which was randomly administered in the first 3 days of life.
Results. FC in the first 7 days of life was higher in the main group (р>0.05). At the PMA of 36 weeks, FC decreased in the main group and increased in the comparison group (p>0.05). FC in the first week of life was higher in infants with EOS compared to newborns without the diseases (p=0.03), followed by a decrease at the PMA of 36 weeks (p=0.04). There was no significant difference in FC levels depending on the development of LOS or NEC. FC levels increased in all infants who received LF and decreased in babies who did not receive LF (p>0.05).
Conclusions. The occurrence of EOS is associated with a significant increase in FC which subsequently decrease by the PMA of 36 weeks. FC in the first week of life are not associated with the development of NEC or LOS. Enteral use of LF at a dose of 100 mg/day is associated with an increase in FC levels (p>0.05).
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
References
Agren MS, auf dem Keller U. (2020). Matrix Metalloproteinases: How Much Can They Do? International Journal of Molecular Sciences. 21 (8): 2678. https://doi.org/10.3390/ijms21082678; PMid:32290531 PMCid:PMC7215854
Apte SS, Parks WC. (2015). Metalloproteinases: A parade of functions in matrix biology and an outlook for the future. Matrix Biology. 44-46: 1-6. https://doi.org/10.1016/j.matbio.2015.04.005; PMid:25916966
Babichev SA. (2014). Optimization of information preprocessing in clustering systems of high dimension data. Radioelektronika, informatyka, upravlinnia. 2: 135-142. URL: https://cyberleninka.ru/article/n/optimizatsiya-protsessa-predobrabotki-informatsii-v-sistemah-klasterizatsii-vysokorazmernyh-dannyh/viewer. https://doi.org/10.15588/1607-3274-2014-2-19
Da Silva-Neto PV, do Valle VB, Fuzo CA, Fernandes TM, Toro DM, Fraga-Silva TFC et al. (2022). Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress. Biomolecules. 12 (5): 604. https://doi.org/10.3390/biom12050604; PMid:35625532 PMCid:PMC9138255
Fingleton B. (2017). Matrix metalloproteinases as regulators of inflammatory processes. Biochimica et Biophysica Acta - Molecular Cell Research. 1864 (11): 2036-2042. https://doi.org/10.1016/j.bbamcr.2017.05.010; PMid:28502592
Gautam SS, O'Toole RF. (2016). Convergence in the Epidemiology and Pathogenesis of COPD and Pneumonia. COPD: Journal of Chronic Obstructive Pulmonary Disease. 13 (6): 790-798. https://doi.org/10.1080/15412555.2016.1191456; PMid:27310416
Gelzo M, Cacciapuoti S, Pinchera B, De Rosa А, Cernera G, Scialò F et al. (2022). Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients. Scientific Reports. 12: 1212. https://doi.org/10.1038/s41598-021-04677-8; PMid:35075175 PMCid:PMC8786927
Gkouveris I, Nikitakis NG, Aseervatham J, Rao N, Ogbureke KUE. (2017). Matrix metalloproteinases in head and neck cancer: current perspectives. Metalloproteinases In Medicine. 4: 47-61. https://doi.org/10.2147/MNM.S105770
Hardy E, Fernandez-Patron C. (2021). Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis. Biomolecules. 11 (3): 390. https://doi.org/10.3390/biom11030390; PMid:33800947 PMCid:PMC7998259
Huang X, Mu X, Deng L, Fu A, Pu E, Tang T, Kong X. (2019). The etiologic origins for chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease. 14: 1139-1158. https://doi.org/10.2147/COPD.S203215; PMid:31213794 PMCid:PMC6549659
Jabłońska-Trypuć A, Matejczyk M, Rosochacki S. (2016). Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. Journal of Enzyme Inhibition and Medicinal Chemistry. 31 (1): 177-183. https://doi.org/10.3109/14756366.2016.1161620; PMid:27028474
Kachkovska VV. (2021). Matrix metalloproteinases as markers of respiratory tract remodeling and potential therapeutic target in patients with bronchial asthma. Eastern Ukrainian Medical Journal. 9 (2): 174-188. https://doi.org/10.21272/eumj
Karamanos NK, Theocharis AD, Piperigkou Z, Manou D, Passi A, Skandalis SS et al. (2021). A guide to the composition and functions of the extracellular matrix. Federation of European Biochemical Societies Journal. 288 (24): 6850-6912. https://doi.org/10.1111/febs.15776; PMid:33605520
Ke J, Ye J, Li M, Zhu Z. (2021). The Role of Matrix Metalloproteinases in Endometriosis: A Potential Target. Biomolecules. 11 (11): 1739. https://doi.org/10.3390/biom11111739; PMid:34827737 PMCid:PMC8615881
Krasnoselsky NV, Sukhin VS, Gertman VZ, Simonova-Pushkar LI. (2018). Applying matrix metalloproteinase in diagnosis and prognosis in oncogynecology. Actual problems of modern medicine. 18 (1): 313-317. URL: https://cyberleninka.ru/article/n/mozhlivosti-diagnostichnogo-ta-prognostichnogo-vikoristannya-matriksnih-metaloproteyinaz-v-onkoginekologiyi.
Laronha H, Caldeira J. (2020). Structure and Function of Human Matrix Metalloproteinases. Cells. 9 (5): 1076. https://doi.org/10.3390/cells9051076; PMid:32357580 PMCid:PMC7290392
Li Y, Fu X, Ma J, Zhang J, Hu Y, Dong W et al. (2019). Altered respiratory virome and serum cytokine profile associated with recurrent respiratory tract infections in children. Nature Communications. 10: 2288. https://doi.org/10.1038/s41467-019-10294-x; PMid:31123265 PMCid:PMC6533328
Potey PM, Rossi AG, Lucas CD, Dorward DA. (2019). Neutrophils in the initiation and resolution of acute pulmonary inflammation: understanding biological function and therapeutic potential. The Journal of Pathology. 247: 672-685. https://doi.org/10.1002/path.5221; PMid:30570146 PMCid:PMC6492013
Raeeszadeh-Sarmazdeh M, Do LD, Hritz BG. (2020). Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics. Cells. 9 (5): 1313. https://doi.org/10.3390/cells9051313; PMid:32466129 PMCid:PMC7290391
Ramírez-Martínez G, Jiménez-Álvarez LA, Cruz-Lagunas A, Ignacio-Cortés S, Gómez-García IA, Rodríguez-Reyna TS et al. (2022). Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae. Journal of Interferon & Cytokine Research. 42 (8): 352-368. https://doi.org/10.1089/jir.2021.0222; PMid:35647937 PMCid:PMC9422783
Sarkar S, Ratho RK, Singh M, Singh MP, Singh A, Sharma M. (2022). Comparative Analysis of Epidemiology, Clinical Features, and Cytokine Response of Respiratory Syncytial and Human Metapneumovirus Infected Children with Acute Lower Respiratory Infections. Japanese Journal of Infectious Diseases. 75 (1): 56-62. https://doi.org/10.7883/yoken.JJID.2021.151; PMid:34193665
Sebina I, Phipps S. (2020). The Contribution of Neutrophils to the Pathogenesis of RSV Bronchiolitis. Viruses. 12 (8): 808. https://doi.org/10.3390/v12080808; PMid:32726921 PMCid:PMC7472258
Voloshin OM, Marushko YuV. (2021). Peculiarities of cellular immunity among preschool children suffering from recurrent respiratory diseases. Bulletin of problems biology and medicine. 1: 337-342. https://doi.org/10.29254/2077-4214-2021-1-159-337-342
XuChen X, Weinstock J, Arroyo M, Salka K, Chorvinsky E, Abutaleb K et al. (2021). Airway Remodeling Factors During Early-Life Rhinovirus Infection and the Effect of Premature Birth. Frontiers in Pediatrics. 9: 610478. https://doi.org/10.3389/fped.2021.610478; PMid:33718297 PMCid:PMC7952989
Young D, Das N, Anowai A, Dufour A. (2019). Matrix Metalloproteases as Influencers of the Cells' Social Media. International Journal of Molecular Sciences. 20 (16): 3847. https://doi.org/10.3390/ijms20163847; PMid:31394726 PMCid:PMC6720954
Zinter MS, Delucchi KL, Kong MY, Orwoll BE, Spicer AS, Lim MJ et al. (2019). Early Plasma Matrix Metalloproteinase Profiles. A Novel Pathway in Pediatric Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 199 (2): 181-189. https://doi.org/10.1164/rccm.201804-0678OC; PMid:30114376 PMCid:PMC6353006
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
